Abstract
Comparative genomic hybridization (CGH) was used to detect copy number changes of DNA sequences in the Ewing family of tumours (ET). We analysed 20 samples from 17 patients. Fifteen tumours (75%) showed copy number changes. Gains of DNA sequences were much more frequent than losses, the majority of the gains affecting whole chromosomes or whole chromosome arms. Recurrent findings included copy number increases for chromosomes 8 (seven out of 20 samples; 35%), 1q (five samples; 25%) and 12 (five samples; 25%). The minimal common regions of these gains were the whole chromosomes 8 and 12, and 1q21-22. High-level amplifications affected 8q13-24, 1q and 1q21-22, each once. Southern blot analysis of the specimen with high-level amplification at 1q21-22 showed an amplification of FLG and SPRR3, both mapped to this region. All cases with a gain of chromosome 12 simultaneously showed a gain of chromosome 8. Comparison of CGH findings with cytogenetic analysis of the same tumours and previous cytogenetic reports of ET showed, in general, concordant results. In conclusion, our findings confirm that secondary changes, which may have prognostic significance in ET, are trisomy 8, trisomy 12 and a gain of DNA sequences in 1q.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Armengol, G., Tarkkanen, M., Virolainen, M. et al. Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization. Br J Cancer 75, 1403–1409 (1997). https://doi.org/10.1038/bjc.1997.242
Issue Date:
DOI: https://doi.org/10.1038/bjc.1997.242
This article is cited by
-
An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma
npj Precision Oncology (2022)
-
CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling
Oncogene (2016)
-
An integrated analysis of miRNA and gene copy numbers in xenografts of Ewing's sarcoma
Journal of Experimental & Clinical Cancer Research (2012)
-
A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion
Nature Genetics (2012)
-
Recent advances in the molecular pathogenesis of Ewing's sarcoma
Oncogene (2010)